Deal Watch: Roivant Spins Out Arvelle, Licenses Epilepsy Candidate From SK Biopharma

 
• By Joseph Haas, Jung Won Shin, Brian Yang, and Ian Haydock
DealWatch_1200x675

More from Strategy

More from Business